The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib plus docetaxel versus docetaxel as second-line treatment for advanced non-small cell lung cancer (NSCLC): Updated results from a phase I/II study.
 
Yong Fang
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Jiawei Shou
No Relationships to Disclose
 
Wei Hong
No Relationships to Disclose
 
Qunyi Guo
No Relationships to Disclose
 
Xinmei Yang
No Relationships to Disclose
 
Dan Zhu
No Relationships to Disclose
 
Jun Chen
No Relationships to Disclose
 
Liqin Lu
No Relationships to Disclose
 
Chuangzhou Rao
No Relationships to Disclose
 
Fen Lan
No Relationships to Disclose